Relationship between pharmacokinetic profile of subcutaneously administered alemtuzumab and clinical response in patients with chronic lymphocytic leukemia

Alemtuzumab serum levels and clinical response after subcutaneous administration (10 mg 3 times/week for six weeks) have been explored in 29 chronic lymphocytic leukemia patients receiving the monoclonal antibody as consolidation. Serum concentrations after each administration gradually increased du...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Montagna, Michela, Montillo, Marco, Avanzini, Maria A., Tinelli, Carmine, Tedeschi, Alessandra, Visai, Livia, Ricci, Francesca, Vismara, Eleonora, Morra, Enrica, Regazzi, Mario
Formato: Artigo
Idioma:Inglês
Publicado: Ferrata Storti Foundation 2011
Assuntos:
Brief Reports
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3105658/
https://ncbi.nlm.nih.gov/pubmed/21330330
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2010.033159
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares